Related Experiment Video
Updated: May 20, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Artificial Intelligence to Promote Racial and Ethnic Cardiovascular Health Equity
Daniel Amponsah1, Ritu Thamman2, Eric Brandt3
1Division of Cardiovascular Medicine and Cardiovascular Institute, Stanford University, Stanford, CA, USA.
Artificial intelligence (AI) can help address racial inequities in cardiology but may also perpetuate bias. Careful development and deployment are crucial for equitable AI in cardiovascular care.
Area of Science:
- Cardiology
- Medical Informatics
- Health Equity
Background:
- Artificial intelligence (AI) offers potential to improve cardiovascular care outcomes.
- AI is envisioned as a tool to detect and mitigate racial and ethnic inequities in cardiovascular medicine.
- However, AI algorithms can harbor and propagate biases, posing a risk to equitable healthcare.
Purpose of the Study:
- To review the landscape of AI in cardiology.
- To examine AI's role in identifying and addressing healthcare inequities.
- To discuss concerns and strategies for equitable AI utilization in cardiovascular health.
Main Methods:
- Review of current literature on AI in cardiology.
- Analysis of AI's potential for bias detection and mitigation.
- Exploration of strategies for promoting diversity in AI research and development.
Main Results:
- AI can be valuable in diagnosing and mitigating racial/ethnic inequities in cardiology.
- AI may inadvertently perpetuate biases due to limited training data diversity and inadequate monitoring.
- Rigorous efforts are needed to address AI limitations and ensure equitable deployment.
Conclusions:
- Implementing AI in cardiovascular care requires meticulous data collection and dataset review.
- Ensuring equitable AI performance necessitates rigorous testing and continuous algorithm surveillance.
- Promoting workforce diversity and stakeholder engagement is crucial for AI-driven cardiovascular health equity.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Stereotypes, Prejudice, and Discrimination
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Pre-Procedural Guidelines for Assessing Blood Pressure
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

